kabutan

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.(2395) Summary

2395
TSE Prime
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
1,626
JPY
+26
(+1.63%)
Jan 29, 3:09 pm JST
10.61
USD
Jan 29, 1:09 am EST
Result
PTS
outside of trading hours
1,626.9
Jan 29, 3:09 pm JST
Summary Chart Historical News Financial Result
PER
19.0
PBR
1.79
Yield
3.08%
Margin Trading Ratio
5.83
Stock Price
Jan 29, 2026
Opening Jan 29, 9:00 am
1,595 JPY 10.41 USD
Previous Close Jan 28
1,600 JPY 10.48 USD
High Jan 29, 1:53 pm
1,628 JPY 10.64 USD
Low Jan 29, 9:17 am
1,568 JPY 10.24 USD
Volume
199,800
Trading Value
0.32B JPY 2.09M USD
VWAP
1603.19 JPY 10.47 USD
Minimum Trading Value
162,600 JPY 1,061 USD
Market Cap
0.07T JPY 0.44B USD
Number of Trades
670
Liquidity & Number of Trades
As of Jan 29, 2026
Liquidity
Slightly High
1-Year Average
919
1-Year High May 1, 2025
5,267
Margin Trading
Date Short Interest Long Margin Positions Ratio
Jan 23, 2026 70,900 842,500 11.88
Jan 16, 2026 73,900 796,800 10.78
Jan 9, 2026 75,900 755,200 9.95
Dec 26, 2025 93,100 704,600 7.57
Dec 19, 2025 70,500 672,100 9.53
Company Profile
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is the domestic leader in preclinical testing services. The company offers services from basic research to contract testing, with a focus on pharmaceutical formulations. It is also involved in regenerative medicine.
Sector
Services
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. primarily operates in the CRO (Contract Research Organization) business, supporting pharmaceutical development. The company also engages in translational research, leveraging its proprietary nasal drug delivery technology and nurturing basic knowledge and technologies from universities and biotech ventures into viable businesses. Additionally, as part of its Medipolis project (a social benefit creation initiative), the company operates geothermal power generation and accommodation facilities utilizing its property in Ibusuki City, Kagoshima Prefecture.